To further explore the possible advantage in efficacy for raising cellular immunity by targeting antigen via anti-CD40 11B6-CD40L, we established EO771 mammary adenocarcinoma tumors [derived from a spontaneous mammary tumor in a female C57BL/6 mouse (26)] in human CD40 transgenic female mice. The gene discussed is CD40; the disease is breast cancer.